Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05422014 · ClinicalTrials.gov registry record · NA

Upper Extremity Life Care Specialist (LCS)

A NA study of Upper Extremity Trauma, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05422014: Recruiting NA study of Upper Extremity Trauma, sponsored by Emory University.

NCT05422014 is a NA study of Upper Extremity Trauma that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05422014, a NA study of Upper Extremity Trauma, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This is a randomized control trial aimed at learning more about LCS position and the value it provides to the patient's who have sustained upper extremity traumas.

Primary Outcome

The NRS is a commonly used pain assessment tool in both clinical practice and research. The NRS asks respondents to rate the intensity of their pain on a scale where "no pain" is scored as 0 and 'the worst pain imaginable" is scored as 10.

Conditions Studied

Interventions

  • BEHAVIORAL Life Care Specialist (LCS)

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-10-17
Est. Completion 2025-12
Phase NA
Emory University

1,208 total trials

What NCT05422014 shows while recruiting

NCT05422014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Upper Extremity Trauma appearing as the primary indexed condition, and to 1 intervention - of which Life Care Specialist (LCS) is the first listed.

NCT05422014 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT05422014 about?

NCT05422014 is a clinical study titled "Upper Extremity Life Care Specialist (LCS)". This is a randomized control trial aimed at learning more about LCS position and the value it provides to the patient's who have sustained upper extremity traumas.

What is the current status of trial NCT05422014?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-10-17. Estimated completion is 2025-12.

What conditions does trial NCT05422014 study?

This clinical trial studies the following conditions: Upper Extremity Trauma.

What interventions are being tested in trial NCT05422014?

The interventions under investigation include: Life Care Specialist (LCS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05422014?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05422014 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT05422014's enrollment target sits among peer trials

80 995th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05422014, the US trial registry maintained by the National Library of Medicine. NCT05422014 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.